Resultado de búsqueda
Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.
Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, ...
Andrew Conrad is a healthcare entrepreneur and investor who leads Verily, a subsidiary of Alphabet. He also serves on the board of Genalyte, a biotech company, and advises SandboxAQ, an edtech startup.
22 de feb. de 2024 · Andy Conrad, the founder of Alphabet Inc.’s life sciences unit Verily, has joined venture capital firm S32 as a general partner as the firm seeks to deepen its investments in the booming...
Google’s head of life sciences Andrew Conrad joins the WSJD Live conference to discuss the company's plan to use magnetic nanoparticles to monitor for signs ...
22 de dic. de 2021 · Gillett, who joined Verily as COO in 2020, will work with CEO Andy Conrad and other executives to grow the Alphabet offshoot. Conrad will focus on long-term strategy, business development and partnerships.
21 de dic. de 2021 · Verily CEO Andy Conrad is taking a longer-term, more strategic role at the Alphabet life sciences company and is promoting chief operating officer Stephen Gillett to president and COO.
